Additional file of Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

Fahmin Basher (Creator)
Payal Dhar (Creator)
Xin Wang (Creator)
Derek A. Wainwright (Creator)
Bin Zhang (Creator)
Jeffrey Sosman (Creator)
Zhe Ji (Creator)
Jennifer Donglan Wu (Creator)

Dataset

Description

Date made available	2020
Publisher	figshare

DOI
10.6084/m9.figshare.12872204

Access Dataset

Creative Commons Attribution 4.0 International

1 Article

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
Basher, F., Dhar, P., Wang, X., Wainwright, D. A., Zhang, B., Sosman, J., Ji, Z. & Wu, J. D., Jun 9 2020, In: Journal of Hematology and Oncology. 13, 1, 74.
Research output: Contribution to journal › Article › peer-review

Open Access
26 Scopus citations

Cite this

Basher, F. (Creator), Dhar, P. (Creator), Wang, X. (Creator), Wainwright, D. A. (Creator), Zhang, B. (Creator), Sosman, J. (Creator), Ji, Z. (Creator), Wu, J. D. (Creator) (2020). Additional file of Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy. figshare. 10.6084/m9.figshare.12872204

Additional file of Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

Description

DOI

Access Dataset

Research output

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

Cite this